皇庭國際(000056.SZ):擬向元禾半導體投資5000萬元
格隆匯3月1日丨皇庭國際(000056.SZ)公佈,為推動公司戰略轉型,探索新業務,公司於近日與元禾(廣州)半導體科技有限公司(簡稱“元禾半導體”或“標的公司”)簽署《投資協議》,元禾半導體為華夏芯(北京)通用處理器技術有限公司(簡稱“華夏芯”)新設立的控股子公司。
華夏芯作為組建標的公司的核心股東,引入皇庭國際作為標的公司的投資者。皇庭國際以投前5億人民幣的估值向標的公司投資5000萬元人民幣,持有標的公司股權9.09%。後續根據相關談判的進展,公司將及時履行審議及信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.